Pembrolizumab-the "KEY" to an evolving landscape in treatment of squamous non-small cell lung cancer (NSCLC).

ABSTRACT:

SUBMITTER: Yellala A 

PROVIDER: S-EPMC7354154 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature